QCBGX
Price
$22.97
Change
-$0.05 (-0.22%)
Updated
Sep 16 closing price
Net Assets
293.61M
RLBFX
Price
$38.69
Change
-$0.01 (-0.03%)
Updated
Sep 16 closing price
Net Assets
263.25B
Interact to see
Advertisement

QCBGX vs RLBFX

Header iconQCBGX vs RLBFX Comparison
Open Charts QCBGX vs RLBFXBanner chart's image
Federated Hermes MDT Balanced C
Price$22.97
Change-$0.05 (-0.22%)
VolumeN/A
Net Assets293.61M
American Funds American Balanced R5
Price$38.69
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets263.25B
QCBGX vs RLBFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QCBGX vs. RLBFX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCBGX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 263B vs. QCBGX (294M). RLBFX pays higher dividends than QCBGX: RLBFX (2.05) vs QCBGX (0.61). QCBGX was incepted earlier than RLBFX: QCBGX (20 years) vs RLBFX (23 years). QCBGX (2.12) is less costly to investors than RLBFX (0.29). QCBGX is a more actively managed with annual turnover of: 68.00 vs. RLBFX (44.00). RLBFX has a lower initial minimum investment than QCBGX: RLBFX (250) vs QCBGX (1500). RLBFX annual gain was more profitable for investors over the last year : 9.77 vs. QCBGX (3.36). RLBFX return over 5 years is better than : 44.27 vs. QCBGX (20.45).
QCBGXRLBFXQCBGX / RLBFX
Total Expense Ratio2.120.29731%
Annual Report Gross Expense Ratio2.120.29731%
Fund Existence20 years23 years-
Gain YTD11.15413.34984%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets294M263B0%
Annual Yield % from dividends0.612.0530%
Returns for 1 year3.369.7734%
Returns for 3 years27.4944.3862%
Returns for 5 years20.4544.2746%
Returns for 10 years50.8882.5562%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRCT39.571.57
+4.13%
PROCEPT BioRobotics Corp
RDY14.730.10
+0.68%
Dr. Reddy's Laboratories Ltd
ASPC10.34N/A
N/A
A Spac III Acquisition Corp
EQV10.38-0.01
-0.10%
EQV Ventures Acquisition Corp
RKDA3.42-0.03
-1.01%
Arcadia Biosciences